Sweden
· Delayed Price · Currency is SEK Enzymatica AB Statistics
Total Valuation
Enzymatica AB has a market cap or net worth of SEK 339.83 million. The enterprise value is 358.81 million.
| Market Cap | 339.83M |
| Enterprise Value | 358.81M |
Important Dates
The next estimated earnings date is Thursday, November 7, 2024.
| Earnings Date | Nov 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Enzymatica AB has 173.38 million shares outstanding. The number of shares has increased by 41.94% in one year.
| Shares Outstanding | 173.38M |
| Shares Change (YoY) | +41.94% |
| Shares Change (QoQ) | +21.95% |
| Owned by Insiders (%) | 26.25% |
| Owned by Institutions (%) | 0.01% |
| Float | 127.87M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.29 |
| PB Ratio | 4.84 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -6.41 |
| EV / Sales | 7.98 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -7.90 |
Financial Position
The company has a current ratio of 1.51, with a Debt / Equity ratio of 38.68.
| Current Ratio | 1.51 |
| Quick Ratio | 0.83 |
| Debt / Equity | 38.68 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.60 |
| Interest Coverage | -23.68 |
Financial Efficiency
Return on equity (ROE) is -65.22% and return on invested capital (ROIC) is -30.74%.
| Return on Equity (ROE) | -65.22% |
| Return on Assets (ROA) | -26.21% |
| Return on Capital (ROIC) | -30.74% |
| Revenue Per Employee | 2.81M |
| Profits Per Employee | -3.50M |
| Employee Count | 18 |
| Asset Turnover | 0.35 |
| Inventory Turnover | 1.19 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -19.01% in the last 52 weeks. The beta is -0.04, so Enzymatica AB's price volatility has been lower than the market average.
| Beta (5Y) | -0.04 |
| 52-Week Price Change | -19.01% |
| 50-Day Moving Average | 2.10 |
| 200-Day Moving Average | 2.85 |
| Relative Strength Index (RSI) | 45.06 |
| Average Volume (20 Days) | 132,413 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Enzymatica AB had revenue of SEK 44.95 million and -55.95 million in losses. Loss per share was -0.33.
| Revenue | 44.95M |
| Gross Profit | 28.76M |
| Operating Income | -54.46M |
| Pretax Income | -56.52M |
| Net Income | -55.95M |
| EBITDA | -51.37M |
| EBIT | -54.46M |
| Loss Per Share | -0.33 |
Balance Sheet
The company has 8.19 million in cash and 27.17 million in debt, giving a net cash position of -18.98 million or -0.11 per share.
| Cash & Cash Equivalents | 8.19M |
| Total Debt | 27.17M |
| Net Cash | -18.98M |
| Net Cash Per Share | -0.11 |
| Equity (Book Value) | 70.25M |
| Book Value Per Share | 0.41 |
| Working Capital | 10.35M |
Cash Flow
In the last 12 months, operating cash flow was -44.91 million and capital expenditures -536,000, giving a free cash flow of -45.44 million.
| Operating Cash Flow | -44.91M |
| Capital Expenditures | -536,000 |
| Free Cash Flow | -45.44M |
| FCF Per Share | -0.26 |
Margins
Gross margin is 63.99%, with operating and profit margins of -121.14% and -124.47%.
| Gross Margin | 63.99% |
| Operating Margin | -121.14% |
| Pretax Margin | -125.73% |
| Profit Margin | -124.47% |
| EBITDA Margin | -114.28% |
| EBIT Margin | -121.14% |
| FCF Margin | -101.09% |
Dividends & Yields
Enzymatica AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -41.94% |
| Shareholder Yield | -41.94% |
| Earnings Yield | -17.06% |
| FCF Yield | -13.37% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |